MarketScreener Editorial Features PureTech Health plc
Equities
PRTC
GB00BY2Z0H74
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.70 GBX | -1.20% |
|
-1.43% | -0.96% |
| Feb. 20 | Inflation's Reality Check | |
| Feb. 20 | PureTech says its pulmonary fibrosis drug granted orphan designation | AN |
MarketScreener Editorial Features
Search
![]() | Inflation's Reality Check | February 20, 2026 at 08:49 am EST |
![]() | Risk on, risk off | February 20, 2026 at 02:19 am EST |
![]() | China’s much-awaited-stimulus keeps markets going | August 29, 2023 at 09:02 am EDT |
| Analyst recommendations: AT&T, Celanese, M&S, Snap, Verizon... | August 29, 2023 at 05:27 am EDT | |
| Global markets live: Exxon Mobil, Eli Lilly, Solvay, Meta, AstraZeneca... | October 11, 2022 at 11:43 am EDT |
No results for this search
- Stock Market
- Equities
- PRTC Stock
- News PureTech Health plc
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions



















